About 20 to 30 percent of women with breast cancer have tumors that are missed by mammogram screening. These interval breast cancers – discovered between routine mammograms – seem to be more...
Targeted therapy drugs transformed the outlook for people with the rare cancers known as gastrointestinal stromal tumors, enabling some to survive a decade or longer. A fraction of GIST patients,...
Average life expectancy had been no better than 18 months for people diagnosed with advanced gastrointestinal stromal tumors, or GISTs. The outlook changed dramatically in 2001 with the arrival...